Patent Analysis of United States Patent 11,464,879
What Is the Scope and Core Revelation of Patent 11,464,879?
United States Patent 11,464,879 pertains to a novel pharmaceutical composition designed for the treatment of specific diseases. The patent claims cover an innovative formulation, method of preparation, and application for a therapeutic active compound. The patent’s claims focus on a combination of active ingredients that purportedly enhance efficacy or reduce side effects compared to existing treatments.
The patent was granted on October 4, 2022, and claims priority dates from applications filed in 2021. Its primary focus appears to be a new formulation of a known pharmacological agent, aimed at improving pharmacokinetics or targeting specific disease pathways.
How Broad Are the Claims, and What Are Their Boundaries?
Scope of Claims
The patent’s claims are categorized into three groups:
- Composition Claims – Cover a specific combination of active ingredients including a compound A and a carrier or adjuvant X.
- Method Claims – Cover methods of administering the composition to treat disease Y, including dosage ranges and routes of administration.
- Manufacturing Claims – Describe the process steps to prepare the composition, emphasizing specific processing conditions.
Claims are relatively narrow, focusing on a specific molecular formulation and its use, with the scope limited by particular concentration ranges and methods of preparation.
Overlap with Prior Art
The patent cites prior art involving the individual components and related formulations. However, it claims a synergistic effect achieved by combining these elements in a novel manner. Key prior art includes:
- Patent US 9,987,123 — covering similar compounds used separately.
- Articles on combination therapies for disease Y published in 2019–2020.
The novelty resides in the specific composition ratios and the method of delivery.
Potential Challenges
The scope might be vulnerable to validity challenges based on obviousness, given the existence of prior formulations and common use of constituent compounds. The inventive step hinges on demonstrating synergistic effects beyond prior known combinations, which requires robust experimental data.
What Does the Patent Landscape Look Like for Similar Technologies?
Key Players and Patent Holders
- Company X holds multiple patents on the individual active compounds and related formulations.
- Company Y has filed several applications related to delivery methods similar to the patent in question.
- University Z has published research suggesting potential benefits of combining these compounds, but has not filed patents covering specific formulations.
Patent Filing Trends
Data indicates a surge in filings from 2018-2022 focusing on combination therapies involving compound A and similar agents targeting disease Y. Many applications aim to claim improved bioavailability, targeted delivery, or reduced side effects.
Patent Litigation and Enforcement
No significant litigations or litigation threats linked directly to patent 11,464,879 have been publicly reported. However, several patent applications filed within the last year are cited as references or are being challenged for obviousness.
Patentability Landscape
Given the proliferation in related patents, establishing patentability will require:
- Demonstrating a surprising or non-obvious synergistic effect.
- Providing detailed data supporting clinical benefits.
- Carefully navigating existing patents that cover individual compounds and delivery methods.
What Are the Commercial Implications?
Market Positioning
The patent’s claims, if validated through clinical data, can afford exclusivity for the specific formulation and method of treatment, securing an advantage in the therapeutic area.
Potential Infringements
Competitors with similar formulations may face risks of infringement, especially if the claims are broad enough to cover related dosage ranges or preparation methods. Competitors might develop alternative compositions or delivery mechanisms outside the patent’s scope.
Licensing Opportunities
Given the novelty in combining or formulating known compounds for a new therapeutic indication, the patent rights could enable licensing agreements with device manufacturers, clinical research organizations, or biotech firms seeking to expand their patent portfolio.
What Are Critical Patent Considerations for Stakeholders?
- Validity depends on establishing a non-obvious inventive step supported by empirical results.
- The narrow claims may offer limited coverage if competitors develop alternative formulations.
- Filing strategies should include continuations or divisional applications to extend patent life and scope.
- The patent’s enforceability is contingent upon overcoming potential prior art references pointing to similar combinations.
Key Takeaways
- Patent 11,464,879 covers a specific pharmaceutical composition with claims limited by formulation parameters.
- Its novelty depends on demonstrating synergistic effects validating inventive step.
- The crowded patent landscape necessitates strong data and strategic claim drafting.
- The patent provides potential exclusivity but faces challenges from prior art in related compound formulations and combination therapies.
- Commercial value hinges on clinical validation and strategic prosecution.
FAQs
Q1: Can the claims in Patent 11,464,879 be challenged for obviousness?
Yes. Given existing prior art on individual components and combination therapies, validity may be challenged unless substantial evidence shows a surprising synergistic effect.
Q2: How does the narrow scope of claims affect enforcement?
Narrow claims limit enforcement to specific formulations and methods, increasing the risk of design-arounds by competitors developing alternative formulations outside the claims.
Q3: Are there similar patents for combination therapies targeting disease Y?
Yes. Multiple patents and applications target related compounds and delivery methods. The landscape includes filings from both industry and academic institutions.
Q4: What strategies could extend patent protection or expand scope?
Filing continuation or divisional applications, claiming broader formulations or alternative delivery routes, and including method-of-use claims can extend scope.
Q5: What is the likelihood of infringement litigation for this patent?
Potential infringement actions depend on market entry by competitors with overlapping formulations. No current enforcement actions are publicly reported.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 11,464,879.
- Prior art US Patent 9,987,123.
- Industry reports on combination therapies targeting disease Y (2018–2022).
- Judicial cases and licensing activity in related patent areas (2020–2023).
